NDC 59651-422 – Cevimeline Hydrochloride

Cevimeline Hydrochloride 30 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC59651-422

Product details

Brand name
Cevimeline Hydrochloride
Generic name
Cevimeline Hydrochloride
Labeler
Aurobindo Pharma Limited
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA215056
Marketed since
April 18, 2023
Listing expires
December 31, 2026
Pharmacologic class
Cholinergic Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cevimeline hydrochloride →

Package NDC codes (2)

Package NDCDescriptionSince
59651-422-01100 CAPSULE in 1 BOTTLE (59651-422-01)Apr 18, 2023
59651-422-05500 CAPSULE in 1 BOTTLE (59651-422-05)Apr 18, 2023

Other Cevimeline hydrochloride products